Fibrinet® PRF Wound Matrix is designed for the management of exuding cutaneous wounds, including diabetic and venous ulcers, and mechanically or surgically debrided wounds. This system is designed to harness and concentrate a patient’s own platelets and associated growth factors into a durable platelet-rich fibrin matrix (PRFM). The system enables clinicians to create a structured, autologous fibrin scaffold that can be applied directly to the wound site to support the body’s natural healing processes. Preclinical models evaluating PRFM have demonstrated sustained concentrations of key growth factors for up to seven days. This easy-to-use system enables clinicians to prepare the matrix at the point of care through a simple workflow: draw, spin, transfer, spin, and apply; allowing integration into existing wound care practices. Available in Single Kit and Double Kit configurations, to treat wounds up to 6 cm² and 12 cm², respectively.
Royal Biologics
201/488.1549
